Delisting Determination, The Nasdaq Stock Market, LLC, October 12, 2023,
G Medical Innovations Holdings Ltd.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of G Medical Innovations Holdings Ltd.,
effective at the opening of the trading session on October 23, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rule 5550(b) and 5250(a)(1).
The Company was notified of the Staff determination on February 16, 2023.
On February 23, 2023, the Company exercised its right to appeal
the Staff determination to the Listing Qualifications Hearings
Panel (Panel) pursuant to Rule 5815. A Panel hearing was held on
April 13, 2023. On May 11, 2023, upon review of the information
provided by the Company, the Panel determined to grant the
Company request to remain listed in the Exchange subject to
a series of milestones. Based on the Company failure to meet the terms
of the exception, on August 22, 2023, the Panel issued a final decision
denying the Company continued listing and notified the Company that trading
in the Company securities would be suspended on August 24, 2023.
The Company did not appeal the Panel decision to the Nasdaq Listing
and Hearing Review Council (Council) and the Council did not call
the matter for review. The Staff determination to delist the Company
became final on October 6, 2023.